NLSPW logo

NLS Pharmaceutics Ltd. Warrant


NLSPW: NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.


Show NLSPW Financials

Consumer Interest
SEC Filings

Recent trades of NLSPW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NLSPW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NLSPW in WallStreetBets Daily Discussion


Recent insights relating to NLSPW

CNBC Recommendations

Recent picks made for NLSPW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NLSPW

Corporate Flights

Flights by private jets registered to NLSPW